Ruling on a challenge brought by the ACLU, a New York court ruled yesterday that the patents held by Myriad Genetics on the BRCA1 and BRCA2 breast cancer genes are invalid. Myriad held the rights to all genetic testing involving these genes, making their use in breast cancer diagnosis subject to patent law. In the US, that meant that the tests involving BRCA1 and BRCA2 were either 1) unavailable, or 2) a lot more expensive.
The judge ruled that genes are discovered, and not invented, and therefore can’t be intellectual property.
The article points out that this could have enormous implications for patents held on human genes, all of which must now be called into question. This is self-evident.
I was wondering, though, if this might go even further (assuming that it won’t be successfully appealed, and you can bet there are whole buildings full of high-dollar lawyers drafting an appeal as we speak).
I know most people here are probably aware of similar patents held by Monsanto in particular on some genes, and their predatory (and largely successful) efforts to monopolize the entire agricultural sector. Their efforts to buy up seed distributors and replace what had, for 10,000 years, been natural, common property, with genetically-modified seeds that must be rebought every planting season are, IMO, the very essence of what is wrong with an absolutely free, unregulated market. Monsanto seems to want to control nothing less than the entire food supply, and they’re going about it from an ecologically classic way: bottom-up. If you control the plants, you control the food web.
For a broad, relatively well-cited treatment of Monsanto’s gene-patent sneakiness, take a look at this (yes, it’s a blog, and I do not vouch for all the particulars on the page, but it’s fairly accurate stuff).
This places humans and the natural world in an untenably precarious bondage to corporate interest, and I’d love to see Monsanto’s back broken, free market be damned in this case. They are, excluding the many valid ecological arguments, patenting that which has, throughout history and across all cultures, the common property. It should stay that way.
So, do you think this decision (once again, assuming it holds up under appeal) will have broader implications outside of strictly human genetics?
One “out” I can see for GM-plants companies is, unfortunately, that their products ARE, in fact, invented and not discovered (if you consider introducing a few genes here and there as “invention”).